Adjuvant Therapy for Stage IB Germ Cell Tumors: One versus Two Cycles of BEP

by Robert A. Huddart, Alison M. Reid
Published 2018-01-01

Circulating Tumour DNA in Muscle-Invasive Bladder Cancer

by Melissa P. Tan, Gerhardt Attard, Robert A. Huddart
Published 2018-08-01

The HSP90 inhibitor NVP-AUY922 radiosensitizes by abrogation of homologous recombination resulting in mitotic entry with unresolved DNA damage.

by Shane Zaidi, Martin McLaughlin, Shreerang A Bhide, Suzanne A Eccles, Paul Workman, Christopher M Nutting, Robert A Huddart, Kevin J Harrington
Published 2012-01-01

Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour

by Alexander P.M. Jay, Mohammed Aldiwani, Michael E. O’Callaghan, Adam K. Pearce, Robert A. Huddart, Erik Mayer, Alison H. Reid, David L. Nicol
Published 2021-07-01

The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy

by Sophie R. de Mol van Otterloo, John P. Christodouleas, Erwin L. A. Blezer, Hafid Akhiat, Kevin Brown, Ananya Choudhury, Dave Eggert, Beth A. Erickson, Corinne Faivre-Finn, Clifton D. Fuller, Joel Goldwein, Shaista Hafeez, Emma Hall, Kevin J. Harrington, Uulke A. van der Heide, Robert A. Huddart, Martijn P. W. Intven, Anna M. Kirby, Susan Lalondrelle, Claire McCann, Bruce D. Minsky, Stella Mook, Marlies E. Nowee, Uwe Oelfke, Kristina Orrling, Arjun Sahgal, Jeffrey G. Sarmiento, Christopher J. Schultz, Robbert J. H. A. Tersteeg, Rob H. N. Tijssen, Alison C. Tree, Baukelien van Triest, William A. Hall, Helena M. Verkooijen
Published 2020-09-01